A review of phage mediated antibacterial applications

References

• CDC, Facility Guidance for Control of Carbapenem-resistant Enterobacteriaceae (CRE) 2015.
   Google Scholar
• UNAS. Antibiotic resistance in Uganda: situation analysis and recommendations. Uganda National Academy of Science; 2015.
   Google Scholar
• Centre for Disease Dynamics Economics and Policy-CDDEP. The state of the world’s antibiotics. Washington DC-New Delhi; 2015.
   Google Scholar
• Economou V, Gousia P. Agriculture and food animals as a source of antimicrobial-resistant bacteria. J Infec drug resist. 2015;8: 49.
   Google Scholar
• Warnes SL, Highmore CJ, Keevil CW. Horizontal transfer of antibiotic resistance genes on abiotic touch surfaces: implications for public health. 2012 3(6); J MBio.
   Google Scholar
• World Health Organization., World health organization estimates of the global burden of foodborne diseases. WHO, Geneva, Switzerland (2015). http://apps.who.int
   Google Scholar
• Lewin S, et al. Estimating the burden of disease attributable to unsafe water and lack of sanitation and hygiene in South Africa in 2000. S. Afr Med Journal; 2007;97(8):755–762.
   Google Scholar
• Fenwick AJS. Waterborne infectious diseases—could they be consigned to history? 2006;313(5790):1077–1081.
   Google Scholar
• Shlaes DM. The perfect storm, in antibiotics. The Netherlands: Springer; 2010. p. 1–7.
   Google Scholar
• Guttman B, Raya R, Kutter EJBBA. Basic phage biology. 4 (2005).
   Google Scholar
• Abedon S. Bacteriophage clinical use as antibacterial “drugs”: utility and precedent. Microbiol. Spectr. 2017;5:BAD-0003-2016.
   Google Scholar
• Kutateladze M, Adamia R. Bacteriophages as potential new therapeutics to replace or supplement antibiotics. G. Eliava Institute of Bacteriophages. Trends Biotechnol. 2010;28(12):591–595.
   PubMed Web of Science ®Google Scholar
• Silva YJ, et al. Phage therapy as an approach to prevent Vibrio anguillarum infections in fish larvae production. 2014;9(12):e114197.
   Google Scholar
• Cortés ME, Bonilla JC, Sinisterra RD. Biofilm formation, control and novel strategies for eradication. 2011;2:896–905. %J Sci Against Microbial Pathog Commun Curr Res Technol Adv.
   Google Scholar
• Abedon S. Bacteriophages and biofilms: ecology. 2011;557: J Phage Therapy Plaques.
   Google Scholar
• Hughes KA, Sutherland IW, Jones M. Biofilm susceptibility to bacteriophage attack: the role of phage-borne polysaccharide depolymerase. 1998;144(11):3039–3047. V %J Microbio.
   Google Scholar
• Wittebole X, De Roock S, Opal S. A historical overview of bacteriophage therapy as an alternative to antibiotics for the treatment of bacterial pathogens. M %J Virulence. 2014;5(1):226–235.
   Google Scholar
• Borysowski J, Międzybrodzki R, Górsk A. Phage therapy: current research and applications. Caister Academic Press; 2014.
   Google Scholar
• Chan BK, et al. Phage treatment of an aortic graft infected with Pseudomonas aeruginosa. 2018;2018(1):60–66.
   Google Scholar
• Kazi M, Annapure US. Bacteriophage biocontrol of foodborne pathogens. J food sci tech. 2016;53(3):1355–1362.
   Google Scholar
• Roy B, et al. Biological inactivation of adhering Listeria monocytogenes by listeriaphages and a quaternary ammonium compound. 1993;59(9):2914–2917.
   Google Scholar
• Greer G. Effects of phage concentration, bacterial density, and temperature on phage control of beef spoilage. J Food Sci. 1988;53(4):1226–1227.
   Google Scholar
• Fischetti VA. Bacteriophage endolysins: a novel anti-infective to control Gram-positive pathogens. Int J Med Microbiol. 2010;300(6):357–362.
   PubMed Web of Science ®Google Scholar
• Le TS, et al. Bacteriophages as biological control agents of enteric bacteria contaminating edible oysters. 2018;75(5):611–619.
   Google Scholar
• Hudson J, et al. Bacteriophages as biocontrol agents in food. 2005;68(2):426–437.
   Google Scholar
• Chatain-LY MH. The factors affecting effectiveness of treatment in phages therapy. 2014;5:51. J Frontiers microbio.
   Google Scholar
• Gill J, Abedon STJAF. Bacteriophage ecology and plants. 2003;1–17.
   Google Scholar
• Colomer-Lluch M, Jofre J, Muniesa M. Antibiotic resistance genes in the bacteriophage DNA fraction of environmental samples. PLoS One. 2011;6(3):e17549.
   PubMed Web of Science ®Google Scholar
• Faruque S, Mekalanos J. Phage-bacterial interactions in the evolution of toxigenic Vibrio cholerae. Virulence. 2012;3(7):556–565.
   PubMed Web of Science ®Google Scholar
• McCallin S, et al. Safety analysis of a Russian phage cocktail: from metagenomic analysis to oral application in healthy human subjects. 2013;443(2):187–196.
   Google Scholar
• Gill JJ, Hyman PJCPB. Phage choice, isolation, and preparation for phage therapy. 2010;11(1):2–14.
   Google Scholar
• Hagens S, Loessner MJJCPB. Bacteriophage for biocontrol of foodborne pathogens: calculations and considerations. 2010;11(1):58–68.
   Google Scholar
• Mahony J, et al. Bacteriophages as biocontrol agents of food pathogens. 2011;22(2):157–163.
   Google Scholar
• Jeon J, et al. In vivo application of bacteriophage as a potential therapeutic agent to control OXA-66-like carbapenemase-producing Acinetobacter baumannii strains belonging to sequence type 357. 2016;82(14):4200–4208.
   Google Scholar
• Alves DR, et al. A novel bacteriophage cocktail reduces and disperses P seudomonas aeruginosa biofilms under static and flow conditions. J Microbial biotech. 2016;9(1):61–74.
   Google Scholar
• Alves D, et al. Combined use of bacteriophage K and a novel bacteriophage to reduce Staphylococcus aureus biofilm formation. J App Environ Microbio. 2014;80(21):6694–6703.
   Google Scholar
• Liu M, et al. Bacteriophage application restores ethanol fermentation characteristics disrupted by Lactobacillusfermentum. 2015;8(1):132.
   Google Scholar
• Dalmasso M, Strain R, Neve H, et al. Three new Escherichia coli phages from the human gut show promising potential for phage therapy. PLoS One. 2016;11(6):e0156773. .
   PubMed Web of Science ®Google Scholar
• Carlton RM, Noordman WH, Biswas B, et al. Bacteriophage P100 for control of Listeria monocytogenes in foods: genome sequence, bioinformatic analyses, oral toxicity study, and application. Regul Toxicol Pharmacol. 2005;43(3):301–312. .
   PubMed Web of Science ®Google Scholar
• Endersen L, Buttimer C, Nevin E, et al. Investigating the biocontrol and anti-biofilm potential of a three phage cocktail against Cronobacter sakazakii in different brands of infant formula. Int J Food Microbiol. 2017;253:1–11.
   PubMed Web of Science ®Google Scholar
• Jun JW, et al. Bacteriophages reduce Yersinia enterocolitica contamination of food and kitchenware. 2018;271:33–47.
   Google Scholar
• Pereira C, et al. Bacteriophages with potential to inactivate Salmonella Typhimurium: use of single phage suspensions and phage cocktails. 2016;220:179–192.
   Google Scholar
• Beims H, et al. Paenibacillus larvae-directed bacteriophage HB10c2 and its application in American foulbrood-affected honey bee larvae. 2015;81(16):5411–5419.
   Google Scholar
• Dini C, De Urraza PJ. Isolation and selection of coliphages as potential biocontrol agents of enterohemorrhagic and Shiga toxin-producing E. coli (EHEC and STEC) in cattle. J Appl Microbiol. 2010;109(3):873–887.
   Web of Science ®Google Scholar
• Ackermann H-W, Tremblay D, Moineau S. Long-term bacteriophage preservation. 2004;38:35e40. WFCC Newsletters.
   Google Scholar
• Jończyk E, et al. The influence of external factors on bacteriophages. 2011;56(3):191–200.
   Google Scholar
• Vandenheuvel D, Lavigne R, Brüssow H. Bacteriophage therapy: advances in formulation strategies and human clinical trials. Annu Rev Virol. 2015;2(1):599–618.
   PubMedGoogle Scholar
• Hyman P, Abedon ST. Bacteriophage host range and bacterial resistance, in advances in applied microbiology. Elsevier; 2010. p. 217–248.
   Google Scholar
• Markoishvili K, et al. A novel sustained‐release matrix based on biodegradable poly (ester amide) s and impregnated with bacteriophages and an antibiotic shows promise in management of infected venous stasis ulcers and other poorly healing wounds. 2002;41(7):453–458.
   Google Scholar
• Jikia D, et al. The use of a novel biodegradable preparation capable of the sustained release of bacteriophages and ciprofloxacin, in the complex treatment of multidrug‐resistant Staphylococcus aureus‐infected local radiation injuries caused by exposure to Sr90. 2005;30(1):23–26.
   Google Scholar
• O’flynn G, et al. Evaluation of a cocktail of three bacteriophages for biocontrol of Escherichia coli O157: H7. J Applied Environ Microbio. 2004;70(6):3417–3424.
   Google Scholar
• Johnson R, et al. Bacteriophages for prophylaxis and therapy in cattle, poultry and pigs. 2008;9(2):201.
   Google Scholar
• Abedon S. Phage therapy dosing: the problem(s) with multiplicity of infection (MOI). Bacteriophage. 2016;6(3):e1220348.
   PubMedGoogle Scholar
• Bach SJ, et al. Effect of bacteriophage DC22 on Escherichia coli O157: H7 in an artificial rumen system (Rusitec) and inoculated sheep. 2003;52(2):89–101.
   Google Scholar
• Majewska J, et al. Oral application of T4 phage induces weak antibody production in the gut and in the blood. 2015;7(8):4783–4799.
   Google Scholar
• Chen L-K, et al. Potential of bacteriophage ΦAB2 as an environmental biocontrol agent for the control of multidrug-resistant Acinetobacter baumannii. 2013;13(1):1–10.
   Google Scholar
• Sutherland IW, et al. The interaction of phage and biofilms. 2004;232(1):1–6.
   Google Scholar
• Kishor C, et al. Phage therapy of staphylococcal chronic osteomyelitis in experimental animal model. Indian J Med Res. 2016;143(1):87–94. .
   PubMedGoogle Scholar
• Wang Y, et al. Intranasal treatment with bacteriophage rescues mice from Acinetobacter baumannii-mediated pneumonia. 2016;11(5):631–641.
   Google Scholar
• Yin S, Huang G, Zhang Y, et al. Phage Abp1 rescues human cells and mice from infection by pan-drug resistant Acinetobacter Baumannii. Cell Physiol Biochem. 2017;44(6):2337–2345. .
   PubMedGoogle Scholar
• EARS-NET., European antimicrobial resistance surveillance network (EARS-Net). 2014. EARS-Net Report,Quarters 1–4. Dublin. 2014. This is a permanent publication in PDF, thus access date not require 
   Google Scholar
• Kateete DP, et al. High prevalence of methicillin resistant Staphylococcus aureus in the surgical units of Mulago hospital in Kampala, Uganda. BMC Res Notes. 2011;4(1):326.
   Google Scholar
• Seni J, et al. Molecular characterization of Staphylococcus aureus from patients with surgical site infections at Mulago Hospital in Kampala, Uganda. PLoS One. 2013;8(6):e66153.
   Web of Science ®Google Scholar
• Pitout JD, Laupland KB. Extended-spectrum beta-lactamase-producing Enterobacteriaceae: an emerging public-health concern. Lancet Infect Dis. 2008;8(3):159–166.
   PubMed Web of Science ®Google Scholar
• EFSA Panel on Biological Hazards. Scientific Opinion on Carbapenem resistance in food animal ecosystems. J EFSA. 2013;11(12):3501.
   Google Scholar
• Nordmann P, Dortet L, Poirel LJTIMM. Carbapenem resistance in Enterobacteriaceae: here is the storm! 2012;18(5):263–272.
   Google Scholar
• CDC, Antibiotic resistance threats in the United States. 2013.
   Google Scholar
• Rose T, et al. Experimental phage therapy of burn wound infection: difficult first steps. 2014;4(2):66.
   Google Scholar
• Sarker S, et al. Oral phage therapy of acute bacterial diarrhea with two coliphage preparations: a randomized trial in children from Bangladesh. 2016;4:124–137.
   Google Scholar
• Verstappen KM, et al. The effectiveness of bacteriophages against methicillin-resistant Staphylococcus aureus ST398 nasal colonization in pigs. PLoS One. 2016;11(8):e0160242.
   Web of Science ®Google Scholar
• Rodríguez-Rubio L, et al. Bacteriophage virion-associated peptidoglycan hydrolases: potential new enzybiotics. Crit Rev Microbiol. 2013;39(4):427–434. .
   PubMed Web of Science ®Google Scholar
• Young R. Phage lysis: do we have the hole story yet? Curr Opin Microbiol. 2013;16(6):790–797.
   Web of Science ®Google Scholar
• Haddad Kashani H, et al. Recombinant endolysins as potential therapeutics against antibiotic-resistant <span class=“named-content genus-species” id=“named-content-1”>Staphylococcus aureus</span>: current status of research and novel delivery strategies. 2018;31(1):e00071–17.
   Google Scholar
• García P, Rodríguez L, Rodríguez A, et al. Food biopreservation: promising strategies using bacteriocins, bacteriophages and endolysins. Trends Food SciTechnol. 2010;21(8):373–382. .
   Web of Science ®Google Scholar
• Borysowski J, Weber-Dąbrowska B, Górski A, et al. Bacteriophage endolysins as a novel class of antibacterial agents. Exp Biol Med (Maywood). 2006;231(4):366–377. .
   PubMed Web of Science ®Google Scholar
• Kusuma C, Jadanova A, Chanturiya T, et al. Lysostaphin-resistant variants of Staphylococcus aureus demonstrate reduced fitness in vitro and in vivo. Antimicrob Agents Chemother. 2007;51(2):475–482. .
   PubMed Web of Science ®Google Scholar
• Viertel T, Ritter K, Horz HP. Viruses versus bacteria-novel approaches to phage therapy as a tool against multidrug-resistant pathogens. J Antimicrob Chemother. 2014;69(9):2326–2336.
   PubMed Web of Science ®Google Scholar
• Mao J, et al. Chimeric Ply187 endolysin kills Staphylococcus aureus more effectively than the parental enzyme. 2013;342(1):30–36.
   Google Scholar
• Yang H, Yu J, Wei H. Engineered bacteriophage lysins as novel anti-infectives. 5(542):2014.
   Google Scholar
• Donovan D, Foster-Frey J. LambdaSa2 prophage endolysin requires Cpl-7-binding domains and amidase-5 domain for antimicrobial lysis of streptococci. FEMS Microbiol Lett. 2008;287(1):22–33.
   Web of Science ®Google Scholar
• Lang LH. FDA approves use of bacteriophages to be added to meat and poultry products. Gastroenterology. 2006;131(5):1370.
   Web of Science ®Google Scholar
• de Oliveira AC, Damasceno QS. [Surfaces of the hospital environment as possible deposits of resistant bacteria: a review]. Rev Esc Enferm USP. 2010;44(4):1118–1123.
   Web of Science ®Google Scholar
• French GL, et al. Tackling contamination of the hospital environment by methicillin-resistant Staphylococcus aureus (MRSA): a comparison between conventional terminal cleaning and hydrogen peroxide vapour decontamination. J Hosp Infect. 2004;57(1):31–37. .
   PubMed Web of Science ®Google Scholar
• Ssekatawa K, et al. A systematic review: the current status of carbapenem resistance in East Africa. BMC Res Notes. 2018;11(1):629. .
   Google Scholar
• D’Accolti M, et al. Efficient removal of hospital pathogens from hard surfaces by a combined use of bacteriophages and probiotics: potential as sanitizing agents. 2018;11:1015.
   Google Scholar
• Ho YH, et al. Application of bacteriophage-containing aerosol against nosocomial transmission of carbapenem-resistant acinetobacter baumannii in an intensive care unit. PLoS One. 2016;11(12):e0168380. .
   PubMed Web of Science ®Google Scholar
• Akimkin V, Shestopalov N, Shumilov V, et al. ICPIC, meeting abstracts from international conference on prevention & infection control (ICPIC 2017), biological disinfection with bacteriophages. Antimicrob Resist Infect Control. 2017;6(3):52.
   Google Scholar
• O’flaherty S, et al. Potential of the polyvalent anti-Staphylococcus bacteriophage K for control of antibiotic-resistant staphylococci from hospitals. 2005;71(4):1836–1842.
   Google Scholar
• Brown TL, et al. The formulation of bacteriophage in a semi solid preparation for control of propionibacterium acnes growth. PLoS One. 2016;11(3):e0151184. .
   PubMed Web of Science ®Google Scholar
• Beckner M, Ivey ML, Phister TG. Microbial contamination of fuel ethanol fermentations. 2011;53(4):387–394.
   Google Scholar
• Silva J, Sauvageau D. Bacteriophages as antimicrobial agents against bacterial contaminants in yeast fermentation processes. J Biotechn biofuels. 2014;7(1):123.
   Google Scholar
• Fish R, et al. Bacteriophage treatment of intransigent diabetic toe ulcers: a case series. 2016;25(Sup7):S27–S33.
   Google Scholar
• Leszczyński P, et al. Successful eradication of methicillin-resistant Staphylococcus aureus (MRSA) intestinal carrier status in a healthcare worker–case report. Folia Microbiol (Praha). 2006;51(3):236–238. .
   PubMed Web of Science ®Google Scholar
• Marza JAS, et al. Multiplication of therapeutically administered bacteriophages in Pseudomonas aeruginosa infected patients. Burns. 2006;32(5):644–646. .
   PubMed Web of Science ®Google Scholar
• Fadlallah A, Chelala E, Legeais J-MJTOOJ. Corneal infection therapy with topical bacteriophage administration. 2015;9:167.
   Google Scholar
• Wright A, et al. A controlled clinical trial of a therapeutic bacteriophage preparation in chronic otitis due to antibiotic‐resistant Pseudomonas aeruginosa; a preliminary report of efficacy. 2009;34(4):349–357.
   Google Scholar
• Khawaldeh A, et al. Bacteriophage therapy for refractory Pseudomonas aeruginosa urinary tract infection. J Med Microbiol. 2011;60(Pt 11):1697–1700. .
   Web of Science ®Google Scholar
• Letkiewicz S, et al. Eradication of Enterococcus faecalis by phage therapy in chronic bacterial prostatitis—case report. 2009;54(5):457.
   Google Scholar
• Roach DR, et al. Bacteriophage-encoded lytic enzymes control growth of contaminating Lactobacillus found in fuel ethanol fermentations. 2013;6(1):20.
   Google Scholar
• Khatibi PA, et al. Saccharomyces cerevisiae expressing bacteriophage endolysins reduce Lactobacillus contamination during fermentation. 2014;7(1):104.
   Google Scholar
• Obeso JM, et al. Use of logistic regression for prediction of the fate of Staphylococcus aureus in pasteurized milk in the presence of two lytic phages. Appl Environ Microbiol. 2010;76(18):6038–6046. .
   PubMed Web of Science ®Google Scholar
• Lee Y-D, Park J-H. Characterization and application of phages isolated from sewage for reduction of Escherichia coli O157:H7 in biofilm. Lebensmittel-Wissenschaft + [i.e. und] Tech. 2015;60(no. 1):571–577–2015.
   Google Scholar
• Tomat D, Mercanti D, Balagué C, et al. Phage biocontrol of enteropathogenic and Shiga toxin-producing Escherichia coli during milk fermentation. Lett Appl Microbiol. 2013;57(1):3–10. .
   PubMed Web of Science ®Google Scholar
• Guenther S, Loessner MJ. Bacteriophage biocontrol of Listeria monocytogenes on soft ripened white mold and red-smear cheeses. J App Bacteri. 2011;1(2):94–100.
   Google Scholar
• Vonasek EL, et al. Incorporating phage therapy into WPI dip coatings for applications on fresh whole and cut fruit and vegetable surfaces. 2018;83(7):1871–1879.
   Google Scholar
• Leverentz B, et al. Biocontrol of Listeria monocytogenes on fresh-cut produce by treatment with lytic bacteriophages and a bacteriocin. 2003;69(8):4519–4526.
   Google Scholar
• Guenther S, et al. Virulent bacteriophage for efficient biocontrol of Listeria monocytogenes in ready-to-eat foods. J App environ microbio. 2009;75(1):93–100.
   Google Scholar
• Deasy T, et al. Isolation of a virulent Lactobacillus brevis phage and its application in the control of beer spoilage. 2011;74(12):2157–2161.
   Google Scholar
• Augustine J, Bhat SG. Biocontrol of Salmonella Enteritidis in spiked chicken cuts by lytic bacteriophages ΦSP‐1 and ΦSP‐3. J basic microbio. 2015;55(4):500–503.
   Google Scholar
• Patel J, et al. Inactivation of Escherichia coli O157: H7 attached to spinach harvester blade using bacteriophage. 2011;8(4):541–546.
   Google Scholar
• Jun JW, et al. Eating oysters without risk of vibriosis: application of a bacteriophage against Vibrio parahaemolyticus in oysters. 2014;188:31–35.
   Google Scholar
• Bandara N, et al. Bacteriophages BCP1-1 and BCP8-2 require divalent cations for efficient control of Bacillus cereus in fermented foods. 2012;31(1):9–16.
   Google Scholar
• Lone A, et al. Development of prototypes of bioactive packaging materials based on immobilized bacteriophages for control of growth of bacterial pathogens in foods. 2016;217:49–58.
   Google Scholar
• Kim KP, Klumpp J, Loessner MJ. Enterobacter sakazakii bacteriophages can prevent bacterial growth in reconstituted infant formula. Int J Food Microbiol. 2007;115(2):195–203.
   PubMed Web of Science ®Google Scholar
• Huang C, et al. Isolation, characterization, and application of a novel specific Salmonella bacteriophage in different food matrices. Food Res Int. 2018;111:631–641.
   PubMed Web of Science ®Google Scholar
• Gouvêa DM, et al. Acetate cellulose film with bacteriophages for potential antimicrobial use in food packaging. 2015;63(1):85–91.
   Google Scholar
• Gouvêa DM, et al. Absorbent food pads containing bacteriophages for potential antimicrobial use in refrigerated food products. 2016;67:159–166.
   Google Scholar
• Pereira C, et al. Application of phage therapy during bivalve depuration improves Escherichia coli decontamination. 2017;61:102–112.
   Google Scholar
• Ryan EM, et al. Synergistic phage-antibiotic combinations for the control of Escherichia coli biofilms in vitro. 2012;65(2):395–398.
   Google Scholar
• Kusmiatun A, Rusmana I, Budiarti S. Characterization of bacteriophage specific to bacillus pumilus from Ciapus River in Bogor, West Java, Indonesia. HAYATI J Biosci. 2015;22(1):27–33.
   Google Scholar
• Kvachadze L, et al. Evaluation of lytic activity of staphylococcal bacteriophage Sb‐1 against freshly isolated clinical pathogens. 2011;4(5):643–650.
   Google Scholar
• Sillankorva S, Neubauer P, Azeredo JJBB. Pseudomonas fluorescens biofilms subjected to phage phiIBB-PF7A. 2008;8(1):79.
   Google Scholar
• Jung L-S, et al. Evaluation of lytic bacteriophages for control of multidrug-resistant Salmonella Typhimurium. 2017;16(1):1–9.
   Google Scholar
• Alves DR, et al. Development of a high-throughput ex-vivo burn wound model using porcine skin, and its application to evaluate new approaches to control wound infection. J Frontiers cellular infec microbio. 2018;8:196.
   Google Scholar
• Ghosh A, et al. Combined application of essential oil compounds and bacteriophage to inhibit growth of Staphylococcus aureus in vitro. 2016;72(4):426–435.
   Google Scholar
• Lungren MP, et al. Bacteriophage K for reduction of Staphylococcus aureus biofilm on central venous catheter material. 2013;3(4):e26825.
   Google Scholar
• Carson L, Gorman S, Gilmore B. The use of lytic bacteriophages in the prevention and eradication of biofilms of Proteus mirabilis  and Escherichia coli. 2010;59(3):447–455.
   Google Scholar
• Nouraldin AAM, et al. Bacteriophage-antibiotic synergism to control planktonic and biofilm producing clinical isolates of Pseudomonas aeruginosa. 2016;52(2):99–105.
   Google Scholar
• Vipra AA, et al. Antistaphylococcal activity of bacteriophage derived chimeric protein P128. 2012;12(1):41.
   Google Scholar
• Chhibber S, Nag D, Bansal SJBM. Inhibiting biofilm formation by Klebsiella pneumoniae B5055 using an iron antagonizing molecule and a bacteriophage. 2013;13(1):1–8.
   Google Scholar
• Abdulamir AS, et al. The potential of bacteriophage cocktail in eliminating Methicillin-resistant Staphylococcus aureus biofilms in terms of different extracellular matrices expressed by PIA, ciaA-D and FnBPA genes. 2015;14(1):49.
   Google Scholar
• Didamony GE, Askora A, Shehata AA. Isolation and characterization of T7-Like Lytic Bacteriophages Infecting multidrug resistant pseudomonas aeruginosa isolated from Egypt. Curr Microbiol. 2015;70(6):786–791.
   Web of Science ®Google Scholar
• Niculae C-M, et al. The 12th Edition of the Scientific Days of the National Institute for Infectious Diseases “Prof. Dr. Matei Bals” and the 12th National Infectious Diseases Conference. 99. Neguț AC, Săndulescu O, Streinu-Cercel A, et al. Influence of bacteriophages on sessile Gram-positive and Gramnegative bacteria. . in BMC Infectious diseases. 2016. BioMed Central.
   Google Scholar
• Woo J, Ahn JJAOM. Assessment of synergistic combination potential of probiotic and bacteriophage against antibiotic-resistant Staphylococcus aureus exposed to simulated intestinal conditions. 2014;196(10):719–727.
   Google Scholar
• Morris J, et al. Evaluation of bacteriophage anti-biofilm activity for potential control of orthopedic implant-related infections caused by Staphylococcus aureus. 2019;20(1):16–24.
   Google Scholar
• Fu W, et al. Bacteriophage cocktail for the prevention of biofilm formation by Pseudomonas aeruginosa on catheters in an in vitro model system. 2010;54(1):397–404.
   Google Scholar
• Olszak T, et al. In vitro and in vivo antibacterial activity of environmental bacteriophages against Pseudomonas aeruginosa strains from cystic fibrosis patients. 2015;99(14):6021–6033.
   Google Scholar
• Guang-Han O, et al. Experimental phage therapy for Burkholderia pseudomallei infection. 2016;11(7):e0158213.
   Google Scholar
• Chhibber S, Gupta P, Kaur SJBM. Bacteriophage as effective decolonising agent for elimination of MRSA from anterior nares of BALB/c mice. 2014;14(1):212.
   Google Scholar
• Abdulamir AS, et al. Novel approach of using a cocktail of designed bacteriophages against gut pathogenic E. colifor bacterial load biocontrol. 2014;13(1):39.
   Google Scholar
• Furusawa T, et al. Phage therapy is effective in a mouse model of bacterial equine keratitis. 2016;82(17):5332–5339.
   Google Scholar
• Yen M, Cairns LS, Camilli AJNC. A cocktail of three virulent bacteriophages prevents Vibrio cholerae infection in animal models. 2017;8(1):1–7.
   Google Scholar
• Augustine J, Gopalakrishnan MV, Bhat SG. Application of ΦSP-1 and ΦSP-3 as a therapeutic strategy against Salmonella Enteritidis infection using Caenorhabditis elegans as model organism. J FEMS Microbio Letters. 2014;356(1):113–117.
   Google Scholar
• Vieira A, et al. Phage therapy to control multidrug-resistant Pseudomonas aeruginosa skin infections: in vitro and ex vivo experiments. 2012;31(11):3241–3249.
   Google Scholar
• Kumari S, Harjai K, Chhibber Sjtjoiidc. Topical treatment of Klebsiella pneumoniae B5055 induced burn wound infection in mice using natural products. 2010;4(6):367–377.
   Google Scholar
• Wei C, et al. Developing a bacteriophage cocktail for biocontrol of potato bacterial wilt. Virol Sin. 2017;32(6):476–484. .
   Web of Science ®Google Scholar
• Kocharunchitt C, Ross T, McNeil DL. Use of bacteriophages as biocontrol agents to control Salmonella associated with seed sprouts. Int J Food Microbiol. 2009;128(3):453–459.
   Web of Science ®Google Scholar
• Elhalag K, et al. Potential use of soilborne lytic Podoviridae phage as a biocontrol agent against Ralstonia solanacearum. J Basic Microbiol. 2018;58(8):658–669. .
   Web of Science ®Google Scholar
• Soleimani-Delfan A, et al. Isolation of Dickeya dadantii strains from potato disease and biocontrol by their bacteriophages. 2015;46(3):791–797.
   Google Scholar
• Tan D, et al. Vibriophages differentially influence biofilm formation by Vibrio anguillarum strains. Appl Environ Microbiol. 2015;81(13):4489–4497.
   Google Scholar
• Khairnar K, et al. Novel bacteriophage therapy for controlling metallo-beta-lactamase producing Pseudomonas aeruginosainfection in Catfish. BMC Vet Res. 2013;9(1):264. .
   Google Scholar
• Christiansen RH, et al. Effect of bacteriophages on the growth of flavobacterium psychrophilum and development of phage-resistant strains. Microb Ecol. 2016;71(4):845–859.
   Web of Science ®Google Scholar
• Stalin N, Srinivasan P. Characterization of Vibrio parahaemolyticus and its specific phage from shrimp pond in Palk Strait, South East coast of India. Biologicals. 2016;44(6):526–533.
   PubMed Web of Science ®Google Scholar
• Kittler S, et al. Effect of bacteriophage application on Campylobacter jejuni loads in commercial broiler flocks. 2013;79(23):7525–7533.
   Google Scholar
• Lau GL, Sieo CC, Tan WS, et al. Characteristics of a phage effective for colibacillosis control in poultry. J Sci Food Agric. 2012;92(13):2657–2663. .
   Web of Science ®Google Scholar
• Belgini DRB, et al. Culturable bacterial diversity from a feed water of a reverse osmosis system, evaluation of biofilm formation and biocontrol using phages. World J Microbiol Biotechnol. 2014;30(10):2689–2700. .
   Web of Science ®Google Scholar
• Maal KB, et al. Isolation and identification of two novel Escherichia Coli bacteriophages and their application in wastewater treatment and coliform’s phage therapy. 2015;8:3. J Jundishapur j microbio.
   Google Scholar
• Bull JJ, Levin BR, DeRouin T, et al. Dynamics of success and failure in phage and antibiotic therapy in experimental infections. BMC Microbiol. 2002;2(1):35.
   Google Scholar